Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1751229

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1751229

STD Diagnostics Market Size, Share & Trends Analysis Report By Application (HIV Testing, HSV Testing, Chlamydia Testing), By Product, By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 156 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

STD Diagnostics Market Growth & Trends:

The global STD diagnostics market size is estimated to reach USD 16.08 billion by 2030, expanding at a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world's first commercialized '3 Ct' PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights:

  • The consumables segment dominated the market in 2024 with a revenue share of 70.01% and is anticipated to grow at the fastest CAGR over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
  • Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
  • Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2024, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries
Product Code: 978-1-68038-686-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. STD Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. STD Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. STD Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. STD Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Instruments and Services
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. STD Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. STD Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. CT/NG testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Syphilis testing
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. PCR testing
      • 5.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Non-PCR testing
      • 5.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Gonorrhea testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. HSV testing
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. PCR testing
      • 5.6.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Non-PCR testing
      • 5.6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. HPV testing
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. HIV testing
    • 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Ureaplasma & Mycoplasma testing
    • 5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Trichomonas
    • 5.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. VZV testing
    • 5.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.11.2. PCR testing
      • 5.11.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.11.3. Non-PCR testing
      • 5.11.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. STD Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. STD Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Immunoassay
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Molecular Diagnostics
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Other
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. STD Diagnostics Market: Location of Testing Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. STD Diagnostics Market: Location of Testing Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Commercial/Private labs
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Public Health Labs
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. STD Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. STD Diagnostics Market Share, By Region, 2024 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. BD
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. F. Hoffmann-La Roche Ltd
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Hologic Inc.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Abbott
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Cepheid (Danaher)
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Qiagen
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. OraSure Technologies, Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Bio-Rad Laboratories, Inc.
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. bioMerieux SA
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Thermo Fisher Scientific, Inc.
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives
    • 9.4.11. Seegene Inc.
      • 9.4.11.1. Participant's Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Recent Developments/ Strategic Initiatives
    • 9.4.12. DiaSorin S.p.A
      • 9.4.12.1. Participant's Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Recent Developments/ Strategic Initiatives
Product Code: 978-1-68038-686-8

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global STD diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 7 North America STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 North America STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 12 U.S. STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 16 Canada STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Canada STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 20 Mexico STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Mexico STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 24 Europe STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 29 UK STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 33 Germany STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Germany STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Germany STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 37 France STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 France STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 France STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 France STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 41 Italy STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Italy STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 45 Spain STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Spain STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 49 Denmark STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Denmark STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 53 Sweden STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 57 Norway STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Norway STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 66 Japan STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 70 China STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 71 China STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 72 China STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 73 China STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 74 India STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 75 India STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 India STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 India STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 78 Australia STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 82 South Korea STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Korea STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Korea STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 86 Thailand STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Thailand STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Thailand STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 90 Latin America STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Latin America STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 95 Brazil STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Brazil STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 99 Argentina STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 103 MEA STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 106 MEA STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 108 South Africa STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 116 UAE STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 118 UAE STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 120 Kuwait STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 STD Diagnostics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 User perspective analysis
  • Fig. 12 STD Diagnostics Market driver impact
  • Fig. 13 Prevalence of STIs by WHO regions (in 2023)
  • Fig. 14 STD Diagnostics Market restraint impact
  • Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 16 Porter's Five Forces Analysis
  • Fig. 17 STD diagnostics product outlook: Key takeaways
  • Fig. 18 STD Diagnostics Market: Product movement analysis
  • Fig. 19 Instruments and Services market, 2018 - 2030 (USD Million)
  • Fig. 20 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 21 Software market, 2018 - 2030 (USD Million)
  • Fig. 22 STD diagnostics application outlook: Key takeaways
  • Fig. 23 STD Diagnostics Market: Application movement analysis
  • Fig. 24 CT/NG testing market, 2018 - 2030 (USD Million)
  • Fig. 25 Prevalence (%) of syphilis by WHO regions
  • Fig. 26 Syphilis testing market, 2018 - 2030 (USD Million)
  • Fig. 27 Syphilis PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 28 Syphilis non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 29 HSV testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Herpes Simplex Virus PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 31 Herpes Simplex Virus non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 32 HPV testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Prevalence (%) of HIV by WHO regions
  • Fig. 34 HIV testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Ureaplasma & mycoplasma testing market, 2018 - 2030 (USD Million)
  • Fig. 36 Trichomonas testing market, 2018 - 2030 (USD Million)
  • Fig. 37 VZV testing market, 2018 - 2030 (USD Million)
  • Fig. 38 VZV PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 39 VZV non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Other testing market, 2018 - 2030 (USD Million)
  • Fig. 41 STD diagnostics technology outlook: Key takeaways
  • Fig. 42 STD Diagnostics Market: Technology movement analysis
  • Fig. 43 Molecular Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 44 Immunoassay market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 STD diagnostics location of testing outlook: Key takeaways
  • Fig. 47 STD Diagnostics Market: Location of testing movement analysis
  • Fig. 48 Laboratory testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Commercial/private labs market, 2018 - 2030 (USD Million)
  • Fig. 50 Public health labs market, 2018 - 2030 (USD Million)
  • Fig. 51 Point of care testing market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional outlook, 2023 & 2030
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 North America SWOT
  • Fig. 55 North America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. Country Dynamics
  • Fig. 57 U.S. Target Disease Prevalence
  • Fig. 58 U.S. STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Country Dynamics
  • Fig. 60 Canada Target Disease Prevalence
  • Fig. 61 Canada STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Target Disease Prevalence
  • Fig. 62 Mexico STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe SWOT
  • Fig. 63 Europe STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 64 UK Country Dynamics
  • Fig. 65 UK Target Disease Prevalence
  • Fig. 66 UK STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Germany Country Dynamics
  • Fig. 68 Germany Target Disease Prevalence
  • Fig. 69 Germany STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 70 France Country Dynamics
  • Fig. 71 France Target Disease Prevalence
  • Fig. 72 France STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 73 Spain Country Dynamics
  • Fig. 74 Spain Target Disease Prevalence
  • Fig. 75 Spain STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 76 Italy Country Dynamics
  • Fig. 77 Italy Target Disease Prevalence
  • Fig. 78 Italy STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark Country Dynamics
  • Fig. 80 Denmark Target Disease Prevalence
  • Fig. 81 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 82 Sweden Country Dynamics
  • Fig. 83 Sweden Target Disease Prevalence
  • Fig. 84 Sweden STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 85 Denmark Country Dynamics
  • Fig. 86 Denmark Target Disease Prevalence
  • Fig. 87 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 88 Asia Pacific SWOT
  • Fig. 89 Asia Pacific STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 90 Japan Country Dynamics
  • Fig. 91 Japan Target Disease Prevalence
  • Fig. 92 Japan STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 93 China Country Dynamics
  • Fig. 94 China Target Disease Prevalence
  • Fig. 95 China STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 96 India Country Dynamics
  • Fig. 97 India Target Disease Prevalence
  • Fig. 98 India STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 99 Australia Country Dynamics
  • Fig. 100 Australia Target Disease Prevalence
  • Fig. 101 Australia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 102 South Korea Country Dynamics
  • Fig. 103 South Korea Target Disease Prevalence
  • Fig. 104 South Korea STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 105 Thailand Country Dynamics
  • Fig. 106 Thailand Target Disease Prevalence
  • Fig. 107 Thailand STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 108 Latin America SWOT
  • Fig. 109 Latin America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 110 Brazil Country Dynamics
  • Fig. 111 Brazil Target Disease Prevalence
  • Fig. 112 Brazil STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 113 Mexico Country Dynamics
  • Fig. 116 Argentina Country Dynamics
  • Fig. 117 Argentina Target Disease Prevalence
  • Fig. 118 Argentina STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 119 Middle East & Africa SWOT
  • Fig. 120 Middle East & Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 121 South Africa Country Dynamics
  • Fig. 122 South Africa Target Disease Prevalence
  • Fig. 123 South Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 124 Saudi Arabia Country Dynamics
  • Fig. 125 Saudi Arabia Target Disease Prevalence
  • Fig. 126 Saudi Arabia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 127 UAE Country Dynamics
  • Fig. 128 UAE Target Disease Prevalence
  • Fig. 129 UAE STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 130 Kuwait Country Dynamics
  • Fig. 131 Kuwait Target Disease Prevalence
  • Fig. 132 Kuwait STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 133 Heat map analysis
  • Fig. 134 Company market share analysis (2024)
  • Fig. 135 Company market position analysis (2024)
  • Fig. 136 Company market position analysis (2024)
  • Fig. 137 Market differentiators
  • Fig. 138 Regional Network Map
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!